EFMC-ACSMEDI MedChem Frontiers 2019

Joint Symposium on Medicinal Chemistry Frontiers

 Krakow, Poland    June 10-13, 2019

Remedying the Diseased Genome with Precision-tailored synthetic Gene Regulators (SynGRs)

Prof. Aseem ANSARI
Prof. Aseem ANSARI
UNIVERSITY OF WISCONSIN-MADISON, Madison, United States
Read more

Mining the Protein Kinase Cysteinome

Dr Tjeerd BARF
Dr Tjeerd BARF
ACERTA PHARMA BV, Oss, The Netherlands
Read more

Chemical Physiology of Antibody Conjugates and Natural Products

Dr Gonçalo BERNARDES
Dr Gonçalo BERNARDES
INSTITUTO DE MEDICINA MOLECULAR, PORTUGAL & UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom
Read more

Charting New Paths in Multi-Target Drug Discovery for Alzheimer’s Disease

Prof. Maria Laura BOLOGNESI
Prof. Maria Laura BOLOGNESI
UNIVERSITY OF BOLOGNA, Bologna, Italy
Read more

Targeted Protein Degradation with Small Molecules: How PROTACs work

Prof. Alessio CIULLI
Prof. Alessio CIULLI
UNIVERSITY OF DUNDEE, Dundee, United Kingdom
Read more

Unnatural Amino Acids as a Tool for Better Understanding of Endoproteases Substrate Specificity

Prof. Marcin DRAG
Prof. Marcin DRAG
WROCLAV UNIVERSITY OF TECHNOLOGY, Wroclaw, Poland
Read more

Exploring Bacterial Genomes for Natural Product Discovery and Development

Prof. Alessandra S.  EUSTAQUIO
Prof. Alessandra S. EUSTAQUIO
UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, United States
Read more

The Huge Potential of Natural Cannabinoids and Synthetic Cannabinoids in Neuroprotection

Prof. Rafael FRANCO
Prof. Rafael FRANCO
UNIVERSITY OF BARCELONA, Barcelona, Spain
Read more

Derivatives of 1,3,5-triazine as a New Trend in the Search for the 5-HT6 Receptor Ligands with Therapeutic Perspectives

Dr Jadwiga HANDZLIK
Dr Jadwiga HANDZLIK
MEDICAL COLLEGE OF JAGIELLONIAN UNIVERSITY, Krakow, Poland
Read more

MMP-9 at the Synapse in the Brain and Mind

Prof. Leszek KACZMAREK
Prof. Leszek KACZMAREK
NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY, Warsaw, Poland
Read more

Design of Orexin-1 Receptor Selective Antagonists

Dr Uta LESSEL
Dr Uta LESSEL
BOEHRINGER INGELHEIM, Biberach an der Riss, Germany
Read more

Safety First: Covalent Inhibitors from a Safety Perspective

Dr Mickael MOGEMARK
Dr Mickael MOGEMARK
ASTRAZENECA, Mölndal, Sweden
Read more

Protein-Ligand Interactions: How Medicinal Chemistry Contributes to the Understanding of Molecular Recognition

Dr Marc NAZARE
Dr Marc NAZARE
FMP, Berlin, Germany
Read more

The Ubiquitin Proteasome System

Prof. Huib OVAA
Prof. Huib OVAA
LEIDEN UNIVERSITY MEDICAL CENTER, Leiden, The Netherlands
Read more

Title to be announced

Prof. Christopher OVERALL
Prof. Christopher OVERALL
UNIVERSITY OF BRITISH COLUMBIA, Vancouver, Canada

Adventures in Functional Assignment and Inhibition of Metallo-Enzymes

Prof. Christopher J. SCHOFIELD
Prof. Christopher J. SCHOFIELD
UNIVERSITY OF OXFORD, Oxford, United Kingdom
Read more

Next Generation GPR119 Agonists as Potential Treatment for Cardiometabolic Diseases

Dr Lothar SCHWINK
Dr Lothar SCHWINK
SANOFI, Frankfurt Am Main, Germany
Read more

Multiple Targeting - The Histamine H3 Receptor Pharmacophore as Central Element

Prof. Holger STARK
Prof. Holger STARK
HEINRICH HEINE UNIVERSITY DÜSSELDORF, Duesseldorf, Germany
Read more

Cannabinoid Receptor Type 2 Modulation to Improve Outcomes for Cartilage Repair in the Osteoarthritic Joint

Prof. Katarzyna STAROWICZ-BUBAK
Prof. Katarzyna STAROWICZ-BUBAK
INSTITUTE OF PHARMACOLOGY, POLISH ACADEMY OF SCIENCES, Krakow, Poland
Read more

G Protein-Coupled Receptors: the Structural Basis for their Pharmacology

Dr Chris TATE
Dr Chris TATE
MRC LABORATORY OF MOLECULAR BIOLOGY, Cambridge, United Kingdom
Read more

Adventures in Targeting Protein Lipdation: Breaking Drug Resistance Using Fragment Deconstruction and Chemical Biology

Prof. Edward TATE
Prof. Edward TATE
IMPERIAL COLLEGE LONDON, London, United Kingdom
Read more

AI-based Chemical Synthesis for Accelerating Drug Discovery

Prof. Mark WALLER
Prof. Mark WALLER
SHANGHAI UNIVERSITY, Shanghai, China
Read more

Applications of Artificial Intelligence in Drug Discovery – Separating Hype From Utility

Dr Pat WALTERS
Dr Pat WALTERS
RELAY THERAPEUTICS, Cambridge, United States
Read more

Augmented Intelligence for Compound Design

Dr Michal WARCHOL
Dr Michal WARCHOL
ARDIGEN, Krakow, Poland
Read more